Lilly's Tirzepatide Set to Become Unprecedented Blockbuster, Surpassing $70 Billion by 2032: An Analysis

Lilly’s Tirzepatide Set to Become Unprecedented Blockbuster, Surpassing $70 Billion by 2032: An Analysis